Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


CCR8 activator
BML-CX101-0010 10 mg 138.00 USD
BML-CX101-0050 50 mg 575.00 USD
Do you need bulk/larger quantities?
Novel small molecule agonist at the CCR8 chemokine receptor (EC50=254nM) with no activity at CCR1, CCR2B, CCR4, CCR5, CXCR2, CXCR3 or CXCR4. Dose dependently increases intracellular calcium and stimulates extracellular acidification in cells expressing human CCR8. Murine CCR8-expressing cells underwent chemotaxis on exposure to this agonist. Inhibits HIV fusion of cells expressing CD4 and CCR8. Small molecule CCR8 agonists represent useful tools for exploring CCR8 biology especially in experiments where the use of the natural protein agonist is impractical.

Product Details

Alternative Name:2-[2-[4-[(3-Phenoxyphenyl)methyl]-1-piperazinyl]ethoxy]ethanol dihydrochloride
Formula:C21H28N2O3 . 2HCl
MW:356.4 . 73.0
Purity:≥98% (TLC)
Appearance:White solid.
Solubility:Soluble in water (5 mg/ml) or DMSO (4 mg/ml).
Shipping:Ambient Temperature
Long Term Storage:Ambient
Use/Stability:Store, as supplied, at room temperature for up to one year.  Store solutions at -20°C for up to 3 months.
Regulatory Status:RUO - Research Use Only
BML-CX101 Structure
Please mouse over
BML-CX101 Structure

Product Literature References

Molecular interaction of a potent nonpeptide agonist with the chemokine receptor CCR8.: P.A. Jensen, et al.; Mol. Pharmacol. 72, 327 (2007), Abstract;
Identification and Characterization of a Potent, Selective Nonpeptide Agonist of the CC Chemokine Receptor CCR8 : C.A. Haskell, et al. ; Mol. Pharmacol. 69, 309 (2006), Abstract; Full Text

Product Toolbox


Certificate of Analysis


By target:
Chemokine receptor
By biological activity:
Chemokine receptor Ligand
Chemokine receptor Activator
By catalog section:


Technical Service
Customer Service